Table 3.
Patient Clinical Characteristics Related to Gender Identity and Transition
| Characteristics | N (%) |
|---|---|
| Socially transitioneda | |
| Yes | 121 (87.7) |
| No | 17 (12.3) |
| Medically transitioningb | |
| Yes | 123 (89.1) |
| No | 16 (11.6) |
| Pubertal blocker usec | |
| Yes | 41 (29.5) |
| No | 98 (70.5) |
| Gender-affirming hormone therapyc | |
| Yes | 106 (76.3) |
| No | 33 (23.7) |
| Gender-affirming surgery | |
| Yes | 20 (14.4) |
| No | 119 (85.6) |
Numbers may not sum to totals due to missing data; column percentages may not sum to 100% due to rounding.
a
Social transition was defined in terms of gender identity presentation (i.e., pronoun use, use of preferred name, dress) both at home and in public (i.e., school or workplace).
b
Medical transition was defined in terms of use of GnRH analogs, gender-affirming hormone therapy and/or surgery.
c
Includes both past and current use of pubertal blockers and gender-affirming hormone therapies.